Trump, Medicare and Generic drug

Trump administration defends Medicare drug price talks in case brought by Novartis
The Department of Justice has filed an appeals court brief supporting the right of Medicare officials to negotiate prescription drug prices, a sign that some consumer advocates said suggests the Trump administration is willing to maintain the controversial program.
Trump is unlikely to end Medicare drug price talks — here's what that means for patients and pharma
Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper savings to outdo his predecessor.
Here's how Trump's tariffs on China could impact drug pricing and other healthcare costs
While Trump's tariffs could have a broad impact on healthcare prices, it is likely they will not have the devastating result that some may be expecting, health policy and trade experts say.
Trump to Meet Pharma Leaders as They Seek Drug Policy Changes
The industry is also pushing for curbs on the rebates they pay pharmacy benefit managers, which act as middlemen between drug companies and consumers, in exchange for favorable pl
Trump to Meet Pharma CEOs to Discuss Drug Pricing, Tariffs, and Medicare Negotiations
U.S. President Donald Trump is set to meet with top pharmaceutical executives on Thursday, a White House official confirmed. The discussions will focus on Medicare drug price negotiations, pharmacy benefit managers (PBMs),
PhRMA CEO: 'Key reforms still need to be enacted' for the price of drugs
PhRMA CEO Steve Ubl discusses, PBM reform, the "pill penalty" with the administration and advocating for pharmaceutical ...
Pritzker vows to address the high cost of prescription drugs in Illinois
Illinois lawmakers continue to push for more regulatory control of pharmacy benefit managers, or PBMs. PBMs act as ...
Sandoz to pay $275 million to settle drug price-fixing case
Swiss generic drug manufacturer Sandoz has agreed to pay $275 million to resolve claims by U.S. consumers and others who ...
ConsumerAffairs1d
Medicare patients facing higher drug costs
A new study from the USC Schaeffer Center shows that out-of-pocket costs for brand-name medications have increased sharply ...
Commonwealth Fund11d
Drug Costs and Their Impact on Care: Insights from Medicare Patients and Providers
Providers are sympathetic to Medicare enrollees’ concerns but don’t agree on their role in helping patients find less costly ...
Forbes7d
Medicare Drug Coverage Is Often Inadequate—Here’s Why
WASHINGTON, DC - OCTOBER 06: Activists protest the price of prescription drug costs in front of the ... [+] U.S. Department of Health and Human Services (HHS) building Your father’s rheumatoid ...
Attack drug costs
Recently, a letter to the editor I wrote was published in the Arkansas Democrat-Gazette on the subject of skyrocketing health-care costs, inclusive of rising pharmaceutical drug prices. I referenced ...
Politico8d
Diet drug boom weighs heavily on state budgets
Colorado’s spending on highly effective but costly weight-loss drugs for state workers more than quadrupled from 2023 to 2024 — and costs have been doubling every six months. Now, the state ...